Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition. - Wikidata - awgldk - TriplyDB

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.

http://www.wikidata.org/entity/Q33559175

about

Suspected non-Alzheimer disease pathophysiology--concept and controversy The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015 Recent imaging advances in neurology.Predicting Alzheimer's Disease Using Combined Imaging-Whole Genome SNP Data Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2 Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology.PART, a distinct tauopathy, different from classical sporadic Alzheimer disease.PART and SNAP.White matter hyperintensities and imaging patterns of brain ageing in the general population.The evolution of preclinical Alzheimer's disease: implications for prevention trials.Memory, executive, and multidomain subtle cognitive impairment: clinical and biomarker findings.Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings Is amyloid-β harmful to the brain? Insights from human imaging studies Relationship between APOE Genotype and Structural MRI Measures throughout Adulthood in the Study of Health in Pomerania Population-Based Cohort.Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease.Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology.Total Brain and Hippocampal Volumes and Cognition in Older American Indians: The Strong Heart Study.Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease.Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum.NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers.Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development.Heterogeneity of neuroanatomical patterns in prodromal Alzheimer's disease: links to cognition, progression and biomarkers.APOE allele frequencies in suspected non-amyloid pathophysiology (SNAP) and the prodromal stages of Alzheimer's Disease.The effect of diagnostic criteria on outcome measures in preclinical and prodromal Alzheimer's disease: Implications for trial design.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years.Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia.Decreased hippocampal metabolism in high-amyloid mild cognitive impairment.Joint associations of β-amyloidosis and cortical thickness with cognition.NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.Measuring cognition and function in the preclinical stage of Alzheimer's disease.

P2860

Q26771270-23E6A3CA-89B3-41B2-AE1C-984C8546DCF4 Q26801654-DD2B5BD2-8990-434C-A1B9-3CB0620FF7BC Q30916063-EF0F4DDF-F3A3-41AA-8E00-8B81887DC3B6 Q30930965-E16BC2E8-559F-4B76-87D4-06D787D247DC Q30981669-9DD42483-DD5D-463A-BEAC-89FB74F189F6 Q33862866-C4AEEF46-B3C0-48AC-9C14-FAAA550B5530 Q34467464-86B4068F-E9C8-4914-B24F-6F585171C3D6 Q34507153-78F1592B-B5D4-4E6A-8294-9443B589FC6D Q34515561-8FF12E49-F173-4BE5-8CAC-5A2E1BB66296 Q34849048-A4C5A24C-2997-42DB-BD36-DA913BFA07D1 Q35889053-7314B97F-C52F-4489-8F47-1BEA0556C9B8 Q36252707-066A7B83-2FBD-406B-A12B-8F49E3CC9B00 Q36260136-9786271D-6D3A-406D-845E-7DEB705E62D3 Q36276506-D09E3B02-641D-46A5-AC72-C694A5AAB68E Q36305487-EC3563A8-951B-4661-B5ED-22F0AAE21B54 Q37188315-DD0C864F-642E-4C39-AA2F-8F0E132C9879 Q37500400-3ABC032B-A66C-431C-AA2A-AC13541FFF0B Q37590021-C75ECB5A-F1C7-4678-AD56-DECAE5C46A3A Q39466317-97BFD3FA-61CF-4803-84C7-31D80668A894 Q40188198-D078E251-C9DB-4E7C-9366-FA255A806F8E Q41140682-CFE3E9F6-8FDC-49DE-A1D3-B0C423AEBE5C Q41654319-8A60021B-3B8B-46F4-A0E7-AA37B4C8E892 Q42630406-C3905014-2113-4E14-AEE9-563B4B16245C Q42656279-4E18C5EF-62E1-46EA-99CD-075B6D7F208E Q45949141-3928F1E4-D55E-491F-900E-3D4B156FD40E Q47123978-5AB55146-BA0D-46C2-AA6D-C255728A8176 Q47134402-CB0BF4B4-F5AB-4F21-A34A-6B59FA16C0DF Q47587631-8F057231-3EA0-4242-94EB-35DE2FBD9B9A Q47784298-4C9E109D-CD6E-49A4-90D2-08E378F03B1B Q47842309-99D721C3-B251-4C75-B9E0-E85ACF3629B8 Q47980580-5D72BDE9-6A88-4B2D-A167-9B6CE13E49BB Q48621788-749C2130-A1ED-4B25-BBE5-BC2C7FB244DC Q50422287-C28D584D-1E1E-495B-B94A-F8C14D1441B3 Q52589491-7E038DE5-B159-4B5A-A852-41A3120314D2 Q55442237-5A803A43-62C0-45A6-AC83-D11F62B30DCA

P2860

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.

http://www.wikidata.org/entity/Q33559175

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.

@ast

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.

@en

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.

@nl

type

label

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.

@ast

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.

@en

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.

@nl

prefLabel

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.

@ast

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.

@en

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.

@nl

P1433

Q33559175-C965E55D-5630-4AD7-9994-69B24021DC69

P1476

Q33559175-B14B635F-B020-4A32-830D-FB80BB5E9143

P2093

Q33559175-100D0B6F-D982-4A91-9B68-918E5D319D0F

Q33559175-640E85D6-BC91-473B-8F84-5E2774FEE628

Q33559175-AC65E2C5-A3CF-47AE-8C5A-E134DD9E09A8

Q33559175-EFD08D42-A6FD-4B38-8979-80955A0DA820

P2860

Q33559175-0B8D7250-B7A1-4494-A836-23A104946897

Q33559175-1369EECB-FC0C-4C39-99B2-0F83D7BD7200

Q33559175-15F37AF0-7B55-4380-A463-F368C0CB19A7

Q33559175-198987BC-581C-4DAF-8135-0B489BA96919

Q33559175-21C8BEBA-51BB-4494-B2A7-17F3040A874A

Q33559175-22939016-F3BC-4625-AC4E-4EFC747D5B21

Q33559175-25F145C7-A8A9-419B-AC0B-EE3954B3BD9E

Q33559175-26EC65C8-B0C8-4207-94CF-B302265AB43C

Q33559175-2C9AC58E-F7FD-4082-B820-0B2B3E666000

Q33559175-304FB431-6E8A-4FC5-8C04-11B6453F1A58

P2888

Q33559175-95DF63E8-7297-40C7-B063-194A5A0DD65D

P304

Q33559175-43F22FA8-6B58-4AF6-949E-C50BBB14B1ED

P31

Q33559175-49C214BE-57F2-4E6F-A70A-172F9601E6E5

P356

Q33559175-D39D38F6-3F17-401B-8AC7-645ADC0AF10E

P478

Q33559175-45AA026A-22C1-41DC-AC48-FD3AADF35119

P50

Q33559175-1D02884D-9AC0-414F-8412-9063A6DD031E

Q33559175-47C3125F-9C27-4C91-8ED8-09EEAB679796

Q33559175-56ADABA6-E9AF-48A5-8651-9D3137FA52F1

Q33559175-74299994-CFA1-4314-82D4-88819B9D160F

Q33559175-76960A27-C66C-4960-9B75-B6398E8CBB78

Q33559175-8D5FB174-F97C-4B20-B3E7-41749352B911

Q33559175-9F83EADF-C947-4A0A-A9CF-B712C8AE2AD6

Q33559175-A2C714EA-6CA2-4C97-9A79-E95A77B75677

Q33559175-DEDFE436-3E3A-40E0-A20B-E3C829D170C5

P577

Q33559175-3BD814DE-8BF3-40BF-892A-D057BE22A9F5

P5875

Q33559175-9062B538-6146-4F9D-8C82-6B7276D0916E

P6179

Q33559175-91D06E92-2356-4E29-B20E-D5EBF6EE662F

P698

Q33559175-C55C1CC4-1AAE-4A5B-B62C-4EBFF595776A

P921

Q33559175-F97F24B2-6368-41DE-9BFB-B29A861C86CF

P932

Q33559175-B04708E5-F0B6-473A-8C35-6E315A828FBE

P356

P1433

Acta neuropathologica communications

P1476

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.

@en

P2093

David A Wolk

http://www.w3.org/2001/XMLSchema#string

Kewei Chen

http://www.w3.org/2001/XMLSchema#string

Leslie M Shaw

http://www.w3.org/2001/XMLSchema#string

Xiao Da

http://www.w3.org/2001/XMLSchema#string

P2860

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Mild cognitive impairment: clinical characterization and outcome

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI)

Relationship between plasma analytes and SPARE-AD defined brain atrophy patterns in ADNI

P2888

P304

26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/2051-5960-2-26

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Christos Davatzikos

Alzheimer's Disease Neuroimaging Initiative

Michael W. Weiner

William J. Jagust

John Q. Trojanowski

Steven E. Arnold

P577

2014-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260608990

http://www.w3.org/2001/XMLSchema#string

P6179

1050188510

http://www.w3.org/2001/XMLSchema#string

P698

24602322

http://www.w3.org/2001/XMLSchema#string

P921

P932

4008258

http://www.w3.org/2001/XMLSchema#string